0.1430EUR0.00%Mkt Cap: 5.05M EURP/E: —Last update: 2026-05-14
Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis…
Industry Peers
Medical Instruments & Suppliesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-2.03
PEG—
P/B0.22
P/S0.39
EV/EBITDA-2.27
EV/Revenue0.24
EPS (TTM)-0.06
EPS (Forward)-0.07
Cash Flow & Leverage
FCF Yield0.98%
FCF Margin0.39%
Operating CF-163.00K EUR
CapEx (TTM)—
Net Debt/EBITDA1.45
Net Debt-1.97M EUR
Technical
SMA 500.1541 (-7.2%)
SMA 2000.1536 (-6.9%)
Beta0.25
S&P 52W Chg24.23%
Avg Vol (30d)122.84K
Avg Vol (10d)126.87K
Technical Indicators
RSI (14)41.4
MACD-0.0030
MACD Signal-0.0020
MACD Hist.-0.0010
BB Upper0.1650 EUR
BB Middle0.1515 EUR
BB Lower0.1380 EUR
BB Width17.81%
ATR (14)0.0078 EUR
Vol Ratio (20d)0.61x
52W Range
0.102027% of range0.2560
52W High0.2560 EUR
52W Low0.1020 EUR
Profitability
Gross Margin72.48%
EBITDA Margin-10.63%
Profit Margin-18.00%
Oper. Margin-13.23%
ROE-9.71%
ROA-7.60%
Revenue Growth16.70%
Earnings Growth—
Balance Sheet
Debt/Equity0.07
Current Ratio2.16
Quick Ratio1.33
Book Value/Sh0.6490 EUR
Cash/Share0.0980 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:2000
Split DateFeb 27, 2024
Ownership
Shares Out.35.54M
Float—
Insiders0.00%
Institutions0.00%
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)0.3300 EUR
Target Range0.3300 EUR – 0.3300 EUR
# Analysts1
Company
Market Cap5.05M EUR
Enterprise Value3.09M EUR
Revenue (TTM)12.81M EUR
Gross Profit9.01M EUR
Net Income (TTM)-2.24M EUR
Revenue/Share0.3690 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
Last Price0.1430 EUR
CountryFR
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINFR001400BVK2